France · Seed startup

Who invested in Signadori Bio

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 6 months ago

Funding summaryUpdated 15 Nov 2026

$13Mraised across 1 round since 2026, from 1 source

Latest round
Seed, $13MMay 2026
Led by
Taiho Ventures
Investors
4 (1 led)
See who backed them

The rounds

  1. May 2026

Everyone who backed them

Taiho VenturesCorporate VC1round, led 1
Sofinnova PartnersVC firm1round
Vivo CapitalPrivate equity1round
Invivo PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Signadori Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Invivo Capital PartnersVC firmPer its own site

Quick answers about Signadori Bio

Who invested in Signadori Bio?

Signadori Bio's investors include Taiho Ventures, Sofinnova Partners, Vivo Capital and Invivo Partners. Taiho Ventures led its latest round.

How much has Signadori Bio raised?

Signadori Bio has raised $13M across 1 round since 2026.

When did Signadori Bio last raise?

Signadori Bio's most recent round was a Seed of $13M in May 2026, led by Taiho Ventures.

What was Signadori Bio's biggest round?

Its most recent round, $13M in May 2026, is also its largest on record.

Who backed Signadori Bio first?

Signadori Bio's first round on record, in May 2026, was backed by Taiho Ventures, Sofinnova Partners and Vivo Capital and 1 others.

What stage is Signadori Bio at?

Signadori Bio's latest named round is a Seed, in May 2026.

Where is Signadori Bio based?

Signadori Bio is based in France.

Who led Signadori Bio's rounds?

Taiho Ventures led the Seed in 2026.

Companies like Signadori Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.